National Surveillance Study on Carbapenem Non-Susceptible Klebsiella pneumoniae in Taiwan: The Emergence and Rapid Dissemination of KPC-2 Carbapenemase

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Chiu, Sheng Kang ^a,b   Wu, Tsu Lan ^c   Chuang, Yin Ching ^d   Lin, Jung Chung ^a   Fung, Chang Phone ^e   Lu, Po Liang ^f   Wang, Jann Tay ^g   Wang, Lih Shinn ^h   Siu, L Kristopher ⁱ   Yeh, Kuo Ming ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

ⁱ NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; CARBAPENEM; CARBAPENEMASE; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; OUTER MEMBRANE PORIN K35; OUTER MEMBRANE PORIN K36; OUTER MEMBRANE PROTEIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CARBAPENEMASE GENE; CONTROLLED STUDY; GENE IDENTIFICATION; KLEBSIELLA PNEUMONIAE; MOLECULAR PHYLOGENY; MULTILOCUS SEQUENCE TYPING; MUTATIONAL ANALYSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN;

EID: 84880764577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069428     Document Type: Article

References (43)

1. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, et al. (2002) Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8: 160-166.
2. Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY, (2012) Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 12: 881-887.
3. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP, (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29: 1099-1106.
4. Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, et al. (2011) Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 69: 357-362.
5. Annual report of Taiwan Nosocomial Infection Surveillance Systems, 2011. Available: http://www.kmuh.org.tw/info/admin/actboard/data/20125112222508.pdf. Accessed 2013 Apr 06.
6. Woodford N, Dallow JW, Hill RL, Palepou MF, Pike R, et al. (2007) Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int J Antimicrob Agents 29: 456-459.
7. Doumith M, Ellington MJ, Livermore DM, Woodford N, (2009) Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63: 659-667.
8. Nordmann P, Cuzon G, Naas T, (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9: 228-236.
9. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, et al. (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45: 1151-1161.
10. Jean SS, Hsueh PR, (2011) High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents 37: 291-295.
11. Landman D, Bratu S, Kochar S, Panwar M, Trehan M, et al. (2007) Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 60: 78-82.
12. Wendt C, Schutt S, Dalpke AH, Konrad M, Mieth M, et al. (2010) First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 29: 563-570.
13. Landman D, Babu E, Shah N, Kelly P, Olawole O, et al. (2012) Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother 67: 1427-1431.
14. Chung KP, Tseng SP, Huang YT, Tsai TH, Teng LJ, et al. (2011) Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. J Antimicrob Chemother 66: 1182-1184.
15. Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing: Twenty-Second Informational Supplement M100-S22. Wayne, PA. USA.
16. Department of Health and Human Services, Food and Drug Administration (2009) Class II special controls guidance document: antimicrobial susceptibility test systems (AST): guidance for industry. Washington, DC. USA. Available: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM169359.pdf. Accessed 2013 Apr 06.
17. European Committee on Antimicrobial Susceptibility Testing (2013) Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0 ed. Available: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_Breakpoint_table_v_3.0.pdf. Accessed 2013 Apr 06.
18. Queenan AM, Bush K (2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20: 440-458, table of contents.
19. Alvarez M, Tran JH, Chow N, Jacoby GA, (2004) Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob Agents Chemother 48: 533-537.
20. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, et al. (2004) Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48: 1249-1255.
21. Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, et al. (1997) Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 41: 647-653.
22. Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO, (1986) Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 24: 330-332.
23. D'Agata EM, Gerrits MM, Tang YW, Samore M, Kusters JG, (2001) Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol 22: 550-554.
24. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
25. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S, (2005) Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43: 4178-4182.
26. Lee CM, Liao CH, Lee WS, Liu YC, Mu JJ, et al. (2012) Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011. Antimicrob Agents Chemother 56: 5016-5022.
27. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing: Twentieth Informational Supplement M100-S20U (June 2010 Update). Wayne, PA, USA.
28. Andrade LN, Curiao T, Ferreira JC, Longo JM, Climaco EC, et al. (2011) Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother 55: 3579-3583.
29. Damjanova I, Toth A, Paszti J, Hajbel-Vekony G, Jakab M, et al. (2008) Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new 'MRSAs'? J Antimicrob Chemother 62: 978-985.
30. Ko KS, Lee JY, Baek JY, Suh JY, Lee MY, et al. (2010) Predominance of an ST11 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol 59: 822-828.
31. Hrabak J, Empel J, Bergerova T, Fajfrlik K, Urbaskova P, et al. (2009) International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum beta-lactamases in a Czech hospital. J Clin Microbiol 47: 3353-3357.
32. Lee MY, Ko KS, Kang CI, Chung DR, Peck KR, et al. (2011) High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 38: 160-163.
33. Pereira PS, de Araujo CF, Seki LM, Zahner V, Carvalho-Assef AP, et al. (2012) Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother.
34. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, et al. (2009) Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53: 3365-3370.
35. Kallen A, Guh A (2012) United States Centers for Disease Control and Prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae. Euro Surveill 17.
36. Mammina C, Palma DM, Bonura C, Anna Plano MR, Monastero R, et al. (2010) Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae Carbapenemase 3 in an intensive care unit in Italy. J Clin Microbiol 48: 1506-1507.
37. Qi Y, Wei Z, Ji S, Du X, Shen P, et al. (2011) ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 66: 307-312.
38. Balm MN, Ngan G, Jureen R, Lin RT, Teo J, (2012) Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. J Clin Microbiol 50: 475-476.
39. Virgincar N, Iyer S, Stacey A, Maharjan S, Pike R, et al. (2011) Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK. J Hosp Infect 78: 293-296.
40. Giske CG, Froding I, Hasan CM, Turlej-Rogacka A, Toleman M, et al. (2012) Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 56: 2735-2738.
41. Ma L, Lu PL, Siu LK, Hsieh MH, (2013) Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. J Med Microbiol 62: 101-107.
42. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, et al. (2005) Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56: 128-132.
43. Centers for Disease Control and Prevention (2012) Guidance for Control of Carbapenem-resistant Enterobacteriaceae. Available: http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf h. Accessed 2013 Apr 06.